跳至主要内容
临床试验/CTRI/2023/09/057461
CTRI/2023/09/057461招募中2/3 期

Open randomized controlled clinical trail to evaluate the efficacy of osto-guard granules asthishrunkhala with milk in low bone mineral density levels in post menopausal women

Dr Rutuja Raghunath More1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2023年9月18日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
84
试验地点
1
主要终点
To evaluate the effect of osto guard granules asthishrunkhala with milk in low bone mineral density that is bmd levels in postmenopausal women

研究概览

简要总结

Menopause is a estrogen deficient phase due to reduced ovarian function which causes low bone mineral density

Current study is randomized controlled clinical trial to check the effectiveness of Osto-guard Granules ie Asthishrunkhala in the management of low bone mineral density in postmenopausal women

Study consist of two groups A and B

Group A Osto-Guard Granules 5gms with milk twice a day after meal

Group B Tab.Calcium 500mg with water once a day in morning

Both for 60 days

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
45.00 Year(s) 至 55.00 Year(s)(—)
性别
Female

入选标准

  • 1 Cases having onset of Menopause within 10 yrs with Bone Mineral Density below minus 1 SD 2 Patients of any occupation religion and socio economic conditions.

排除标准

  • 1 Patients diagnosed with osteoporosis BMD less than -2.5 SD 2 Premature ovarian failure Loss of normal functions of ovaries before the age of 40 years 3 Surgical menopause that is Hysterectomy 4 Endocrine disorders like Thyroid disease 5 Pagets disease 6 Malignancy 7 Postmenopausal bleeding.

结局指标

主要结局

To evaluate the effect of osto guard granules asthishrunkhala with milk in low bone mineral density that is bmd levels in postmenopausal women

时间窗: 8 Weeks

次要结局

  • To observe the effect of osto guard granules with milk on serum calcium levels(8 weeks)

研究者

发起方
Dr Rutuja Raghunath More
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验